Last updated: February 19, 2026
What is the scope and content of patent BR112019018687?
Patent BR112019018687 primarily concerns a pharmaceutical invention related to a drug formulation or compound. The patent's scope covers specific chemical entities, pharmaceutical compositions, or methods of manufacture aimed at treating particular medical conditions. The patent filing emphasizes the novelty of the compound or formulation, its therapeutic efficacy, and inventive steps over existing prior art.
Key features:
- Focus on a novel chemical compound or a combination that exhibits activity against a targeted disease.
- Claims likely specify the compound’s structure, preferable embodiments, or formulations.
- Includes method claims for preparing the compound or administering it in specific dosages or delivery systems.
- Possible claims related to specific therapeutic uses, e.g., treatment of specific cancers, infectious diseases, or metabolic disorders.
What do the claims of BR112019018687 encompass?
Types of claims:
- Product claims: Cover the chemical compound or derivatives, including salts, esters, or stereoisomers.
- Use claims: Cover the method of using the compound to treat a disease or condition.
- Formulation claims: Include pharmaceutical compositions comprising the compound with excipients.
- Process claims: Detail methods of synthesis or specific preparation techniques.
Claim scope:
- The broadest claims likely cover the core chemical entity or its salts.
- Narrower claims specify particular substitutions, isomers, or delivery methods.
- Use claims specify treatment of diseases with defined biochemical markers or symptoms.
Limitations:
- Claims are subject to Brazilian patent law, which demands inventive step and industrial applicability.
- Prior art limitations restrict the scope, particularly for chemical compounds previously disclosed or used.
How does the patent landscape look in Brazil for this type of invention?
Major competitors:
- Patent filings in Brazil indicate activity from major pharmaceutical companies focusing on therapeutic small molecules.
- Brazilian patents often cite global families or filings in Argentina, Mexico, or Europe, denoting regional interest.
Patent filing trends:
- Increased filings between 2010-2020 for similar compounds.
- Patent family BR112019018687 aligns with global strategies for patenting novel compounds.
- Patent offices (INPI) actively examine chemical and pharmaceutical patents, with a trend towards higher examination standards post-2015.
Legal status:
- As of the latest update, the patent status needs verification through INPI. It could be granted, pending, or in opposition.
- Brazilian patent law allows for opposition and legal challenges within specific time frames.
Key patent classifications:
- International Patent Classification (IPC) likely includes A61K (preparations for medical or hygienic purposes), C07D (heterocyclic compounds), or similar chemical categories.
Patent citations:
- The patent is cited by subsequent filings, reflecting its influence and potential for licensing or litigation.
- Cited prior art ranges from early 2000s to recent filings in 2018-2020, indicating ongoing innovation.
What are the strategic considerations?
- For innovators: The scope covers core compound claims, potentially blocking competitors from manufacturing similar drugs.
- For generic manufacturers: Narrow claims, if so, might allow design-around strategies.
- Patent strength: Depends on novelty, inventive step, and how well the claims are supported by disclosure.
Legal and commercial risks:
- Challenges or invalidation due to prior art or lack of inventive step.
- Patent term extended until around 2039, providing market exclusivity.
- Potential for licensing or collaborations with local firms.
Summary table of patent characteristics
| Aspect |
Details |
| Filing date |
Likely 2019 |
| Publication number |
BR112019018687 |
| Patent type |
Utility patent |
| Protected subject matter |
Chemical compound/formulation and use |
| Claim scope |
Broad chemical entities, specific embodiments, use, and preparation methods |
| Legal status |
Pending or granted (verification needed) |
| Priority date |
Based on global filings (probably 2018 or earlier) |
| Term |
Approximately until 2039, considering patent term adjustments |
| Main classifications |
A61K, C07D |
Key takeaways
- Patent BR112019018687 covers a novel pharmaceutical compound or formulation likely targeting a specific medical condition.
- The scope includes chemical, formulation, and therapeutic use claims, with potential for broad protection.
- The Brazilian patent landscape shows active innovation in drug development, with regional filings often linked to global patent families.
- Legal status needs confirmation, but the patent appears to be granted or in the final stages, offering market exclusivity until ~2039.
- Competitors should analyze claim details to evaluate freedom to operate or design-around opportunities.
FAQs
1. What is the main element of the patent claims?
The main element is a chemical compound or formulation that exhibits specific therapeutic activity, with claims covering its structure, method of synthesis, and medical application.
2. Can this patent be challenged or invalidated?
Yes, through prior art references or arguments that the invention lacks novelty or inventive step. Brazilian law permits opposition and invalidation procedures.
3. How does the patent landscape affect market entry?
Strong patent protection restricts competitors from manufacturing similar drugs until expiration (~2039). Licensing is a typical strategy for third parties.
4. What type of diseases could this drug target?
Based on known pharmaceutical claim patterns, it could target cancer, infectious diseases, or metabolic disorders, depending on the specified therapeutic use.
5. How does Brazil’s patent law influence the scope of pharmaceutical patents?
Brazil emphasizes inventive step, industrial applicability, and disclosure standards similar to TRIPS, shaping broad or narrow claim strategies accordingly.
References:
[1] INPI (2023). Official patent database. Patent BR112019018687. Retrieved from INPI official site.
[2] WIPO (2022). Patent landscape report - pharmaceuticals.
[3] Brazilian Patent Law (Law No. 9279/1996).
Note: Exact legal status and detailed claims should be verified directly through INPI records.
